A consensus paper published in 2025 provides pragmatic advice on the diagnosis and treatment of subsyndromal anxiety disorder (SSA). If it has been established that the patient has SSA, it is recommended that non-drug treatment measures be initiated first. If this does not lead to the desired success, drug therapy should be considered. Phytotherapeutic treatment with a standardized lavender oil extract has been shown to be effective and safe in studies of SSA.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Why lipoprotein(a) is the biggest therapeutic vacuum in cardiology
Lp(a): The underestimated risk factor before the turning point
- Modern system therapeutics for hidradenitis suppurativa
Immunological dysregulation in the sights of several biologics and “small molecules”
- Perimenopausal depression, PMDS and tokophobia
Psychosomatics and mental health in gynecology
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Proteins in wound healing
Do special amino acids lead to success?
- Polycystic ovary syndrome 2025/2026
New pathophysiology, updated diagnostics and the age of incretin mimetics
- Heart failure and type 2 diabetes
Oral semaglutide and cardiac decompensation in type 2 diabetes
- Atopic dermatitis as a door opener for an atopic cascade?